WEKO3
インデックスリンク
アイテム
{"_buckets": {"deposit": "2292fef3-a4ed-4e7b-a1a0-691c65fb7ad8"}, "_deposit": {"created_by": 3, "id": "12941", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "12941"}, "status": "published"}, "_oai": {"id": "oai:kanazawa-u.repo.nii.ac.jp:00012941", "sets": ["1134"]}, "author_link": ["20071", "20069", "438", "20068", "20067", "389", "20070"], "item_4_biblio_info_8": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2004-09-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "9", "bibliographicPageEnd": "786", "bibliographicPageStart": "779", "bibliographicVolumeNumber": "43", "bibliographic_titles": [{"bibliographic_title": "Internal Medicine"}]}]}, "item_4_description_21": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objective. The optimal approach to relatively recent onset type 2 diabetes patients is still unknown. We speculated that the use of short-acting insulin analogs might be of particular benefit in this context. Patients and Methods. To explore this possibility, we compared the effect on β- and α-cell function of transient intensive insulin therapy using lispro versus human regular insulin in a total of 21 type 2 diabetic patients who were randomly assigned to 14-days intensive insulin therapy consisting of bedtime NPH insulin plus three injections of mealtime lispro (n=11) or regular insulin (n=10). The dosages of both types of insulin were adjusted to attain preprandial glucose levels of \u003c6.1 mmol/l within 1 week with similar rates of glucose decline. An oral glucose tolerance test (OGTT) was performed at day 0 (baseline), 7, and 14; plasma glucose, serum insulin, and plasma glucagon responses over 0-120 minutes were measured, and calculated as the area under the curve (AUC). Results. Lispro led to a significant reduction in glucose-AUC and also an increase in insulin-AUC versus regular insulin on day 7. Glucagon secretion following OGTT was well suppressed with lispro on day 14 compared to regular insulin. Conclusion. Two-week intensive insulin therapy with lispro appeared to be more effective than that with regular insulin in type 2 diabetes in attaining both more rapid β-cell rest and greater suppression of glucagon. These changes may provide significant long-term benefits.", "subitem_description_type": "Abstract"}]}, "item_4_description_5": {"attribute_name": "提供者所属", "attribute_value_mlt": [{"subitem_description": "金沢大学大学院医学系研究科 ", "subitem_description_type": "Other"}]}, "item_4_publisher_17": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本内科学会"}]}, "item_4_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.43.779", "subitem_relation_type_select": "DOI"}}]}, "item_4_rights_23": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "学会"}]}, "item_4_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AA1132885X", "subitem_source_identifier_type": "NCID"}]}, "item_4_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0918-2918", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_25": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Murase, Yuko"}], "nameIdentifiers": [{"nameIdentifier": "20067", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yagi, Kunimasa"}], "nameIdentifiers": [{"nameIdentifier": "438", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "30293343", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=30293343"}, {"nameIdentifier": "30293343", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=30293343"}, {"nameIdentifier": "30293343", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000030293343"}]}, {"creatorNames": [{"creatorName": "Sugihara, Masako"}], "nameIdentifiers": [{"nameIdentifier": "20068", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Chujo, Daisuke"}], "nameIdentifiers": [{"nameIdentifier": "20069", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Otsuji, Michiko"}], "nameIdentifiers": [{"nameIdentifier": "20070", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Muramoto, Hiroaki"}], "nameIdentifiers": [{"nameIdentifier": "20071", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mabuchi, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "389", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "00019960", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=00019960"}, {"nameIdentifier": "00019960", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000000019960"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-10-03"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "ME-PR-MABUCHI-H-P779.pdf", "filesize": [{"value": "91.9 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 91900.0, "url": {"label": "ME-PR-MABUCHI-H-P779.pdf", "url": "https://kanazawa-u.repo.nii.ac.jp/record/12941/files/ME-PR-MABUCHI-H-P779.pdf"}, "version_id": "69e77262-0e12-4695-90cf-c57ab48b580e"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Diabetes mellitus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Insulin lispro", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Transient intensive insulin therapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes"}]}, "item_type_id": "4", "owner": "3", "path": ["1134"], "permalink_uri": "http://hdl.handle.net/2297/7194", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-10-03"}, "publish_date": "2017-10-03", "publish_status": "0", "recid": "12941", "relation": {}, "relation_version_is_last": true, "title": ["Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes"], "weko_shared_id": -1}
Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes
http://hdl.handle.net/2297/7194
http://hdl.handle.net/2297/719492009b47-3e5c-43e6-9bf8-996f55c88eb5
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-MABUCHI-H-P779.pdf (91.9 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Murase, Yuko
× Murase, Yuko× Yagi, Kunimasa× Sugihara, Masako× Chujo, Daisuke× Otsuji, Michiko× Muramoto, Hiroaki× Mabuchi, Hiroshi |
|||||
提供者所属 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 金沢大学大学院医学系研究科 | |||||
書誌情報 |
Internal Medicine 巻 43, 号 9, p. 779-786, 発行日 2004-09-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0918-2918 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA1132885X | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.43.779 | |||||
出版者 | ||||||
出版者 | 日本内科学会 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objective. The optimal approach to relatively recent onset type 2 diabetes patients is still unknown. We speculated that the use of short-acting insulin analogs might be of particular benefit in this context. Patients and Methods. To explore this possibility, we compared the effect on β- and α-cell function of transient intensive insulin therapy using lispro versus human regular insulin in a total of 21 type 2 diabetic patients who were randomly assigned to 14-days intensive insulin therapy consisting of bedtime NPH insulin plus three injections of mealtime lispro (n=11) or regular insulin (n=10). The dosages of both types of insulin were adjusted to attain preprandial glucose levels of <6.1 mmol/l within 1 week with similar rates of glucose decline. An oral glucose tolerance test (OGTT) was performed at day 0 (baseline), 7, and 14; plasma glucose, serum insulin, and plasma glucagon responses over 0-120 minutes were measured, and calculated as the area under the curve (AUC). Results. Lispro led to a significant reduction in glucose-AUC and also an increase in insulin-AUC versus regular insulin on day 7. Glucagon secretion following OGTT was well suppressed with lispro on day 14 compared to regular insulin. Conclusion. Two-week intensive insulin therapy with lispro appeared to be more effective than that with regular insulin in type 2 diabetes in attaining both more rapid β-cell rest and greater suppression of glucagon. These changes may provide significant long-term benefits. | |||||
権利 | ||||||
権利情報 | 学会 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |